What is Pinealon?
The 2011 primary Pinealon study describes a synthetic three-amino-acid peptide with the sequence Glu-Asp-Arg. The Pinealon 20mg vial name refers to that research topic, but its listed amount does not verify a match to the experimental material. Pinealon cell-stress study.
The experiment examined cerebellar granule cells, neutrophils and PC12 cells under induced oxidative stress. Pinealon cell-stress study.
Oxidative-stress and cell-death measurements
One measurement concerned accumulation of reactive oxygen species under induced oxidative stress. Another assessed necrotic cell death using a propidium-iodide test. These are separate cellular endpoints in the paper, rather than measurements of memory, cognition or lifespan in people. Pinealon cell-stress study.
Both belong to the named cell systems under experimentally induced conditions. Neither endpoint should be substituted with a human outcome the experiment did not measure. Pinealon cell-stress study.
Pinealon vial versus pen
The catalogue identifies a 20mg vial. That amount is not a concentration or a human-use instruction, and the cell study did not evaluate the supplier vial. Its sequence and assays cannot establish human cognitive or longevity benefits for the listing. Pinealon cell-stress study.
The separately documented Pinealon 20mg Pen provides the nearest format comparison. The same nominal amount does not demonstrate equivalent formulation, contents or biological performance; the supported science remains the 2011 cellular experiment. Pinealon cell-stress study.
